Cost-effectiveness of Dalteparin Versus Unfractionated Heparin as Venous Thromboembolism Prophylaxis in Malignant Gynecologic Surgery

Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma

Journal of Trauma and Acute Care Surgery ◽

10.1097/ta.0000000000001494 ◽

2017 ◽

Vol 83 (1) ◽

pp. 151-158 ◽

Cited By ~ 31

Author(s):

Benjamin N. Jacobs ◽

Anne H. Cain-Nielsen ◽

Jill L. Jakubus ◽

Judy N. Mikhail ◽

John J. Fath ◽

...

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Unfractionated Heparin ◽

Low Molecular Weight Heparin ◽

Low Molecular Weight ◽

A decision-tree model to estimate the impact on cost-effectiveness of a venous thromboembolism prophylaxis guideline

BMJ Quality & Safety ◽

10.1136/qshc.2007.023135 ◽

2009 ◽

Vol 18 (4) ◽

pp. 309-313 ◽

Cited By ~ 5

Author(s):

A Ferrando ◽

E Pagano ◽

L Scaglione ◽

M Petrinco ◽

D Gregori ◽

...

Keyword(s):

Venous Thromboembolism ◽

Cost Effectiveness ◽

Decision Tree ◽

Decision Tree Model ◽

Tree Model ◽

Prophylaxis Guideline ◽

The Impact

Cost-effectiveness of fondaparinux vs. enoxaparin as venous thromboembolism prophylaxis in Sweden

The European Journal of Health Economics ◽

10.1007/s10198-003-0175-4 ◽

2003 ◽

Vol 4 (4) ◽

pp. 254-262 ◽

Cited By ~ 15

Author(s):

Jonas Lundkvist ◽

David Bergqvist ◽

Bengt J�nsson

Keyword(s):

Venous Thromboembolism ◽

Cost Effectiveness ◽

Cost-effectiveness of venous thromboembolism prophylaxis in total hip and knee replacement surgery: the evolving application of health economic modelling over 20 years

Current Medical Research and Opinion ◽

10.1185/03007990802443255 ◽

2008 ◽

Vol 24 (10) ◽

pp. 2993-3006 ◽

Cited By ~ 13

Author(s):

S.E. Wolowacz ◽

N. Hess ◽

V.K. Brennan ◽

B.U. Monz ◽

J.M. Plumb

Keyword(s):

Health Economic ◽

Venous Thromboembolism ◽

Cost Effectiveness ◽

Knee Replacement ◽

Economic Modelling ◽

Knee Replacement Surgery ◽

Replacement Surgery ◽

Health Economic Modelling

PCV85 - COST-EFFECTIVENESS OF BETRIXABAN COMPARED WITH ENOXAPARIN OR FONDAPARINUX FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS IN HOSPITALISED ACUTE MEDICALLY ILL PATIENTS IN THE UNITED KINGDOM

Value in Health ◽

10.1016/j.jval.2018.09.631 ◽

2018 ◽

Vol 21 ◽

pp. S106-S107

Author(s):

V. Laskier ◽

H. Guy ◽

M. Fisher ◽

W.R. Neuman ◽

I. Bucior ◽

...

Keyword(s):

United Kingdom ◽

Venous Thromboembolism ◽

Cost Effectiveness ◽

Medically Ill ◽

The United Kingdom ◽

Medically Ill Patients

Cost-Effectiveness of Extended Duration Venous Thromboembolism Prophylaxis in High Risk Urological Oncology Surgical Patients

Urology Practice ◽

10.1016/j.urpr.2015.08.004 ◽

2016 ◽

Vol 3 (4) ◽

pp. 262-269 ◽

Cited By ~ 2

Author(s):

Janet E. Baack Kukreja ◽

Helen R. Levey ◽

Ahmed Ghazi ◽

Hani Rashid ◽

Guan Wu ◽

...

Keyword(s):

Venous Thromboembolism ◽

Cost Effectiveness ◽

High Risk ◽

Surgical Patients ◽

Urological Oncology ◽

Extended Duration

Cost–effectiveness of extended venous thromboembolism prophylaxis with fondaparinux in hip surgery patients

Expert Review of Pharmacoeconomics & Outcomes Research ◽

10.1586/14737167.6.2.171 ◽

2006 ◽

Vol 6 (2) ◽

pp. 171-180 ◽

Cited By ~ 4

Author(s):

Matthias Bischof ◽

Jörg D Leuppi ◽

Pedram Sendi

Keyword(s):

Venous Thromboembolism ◽

Cost Effectiveness ◽

Hip Surgery ◽

Venous Thromboembolism Prophylaxis following Acute Ischemic Stroke: A Retrospective Comparison of Unfractionated Heparin, Enoxaparin, and Fondaparinux

Hospital Pharmacy ◽

10.1310/hpj4602-110 ◽

2011 ◽

Vol 46 (2) ◽

pp. 110-116 ◽

Cited By ~ 1

Author(s):

Christina Foley ◽

Joseph G. Ottinger

Keyword(s):

Ischemic Stroke ◽

Venous Thromboembolism ◽

Unfractionated Heparin ◽

Acute Ischemic Stroke ◽

Retrospective Comparison

The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran

DARU Journal of Pharmaceutical Sciences ◽

10.1007/s40199-019-00292-1 ◽

2019 ◽

Vol 27 (2) ◽

pp. 627-634

Author(s):

Mohammadreza Amirsadri ◽

Sarah Mousavi ◽

Ali Karimipour

Keyword(s):

Venous Thromboembolism ◽

Cost Effectiveness ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Medical Inpatients ◽

The Cost

Anticoagulant activity of enoxaparin and unfractionated heparin for venous thromboembolism prophylaxis in obese patients undergoing sleeve gastrectomy

Surgery for Obesity and Related Diseases ◽

10.1016/j.soard.2018.12.014 ◽

2019 ◽

Vol 15 (3) ◽

pp. 363-373 ◽

Cited By ~ 4

Author(s):

Luigi Brunetti ◽

Andrew Wassef ◽

Ragui Sadek ◽

Kiran Deshpande ◽

Jane Ziegler ◽

...

Keyword(s):

Sleeve Gastrectomy ◽

Venous Thromboembolism ◽

Unfractionated Heparin ◽

Anticoagulant Activity ◽

Obese Patients ◽